Android app on Google Play

GlaxoSmithKline (GSK) Posts Improved Q4 EPS of 32.6p; Revs Ease

February 6, 2013 7:21 AM EST Send to a Friend
GlaxoSmithKline (NYSE: GSK) reported Q4 EPS of 32.6p, versus 31.2p reported last year. Revenue for the quarter came in at GBP6.8 billion, versus GBP6.98 billion reported last year.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment